In a continuing medical education program presented at Psych Congress Regionals 2021, faculty presented on a wide range of topics in tardive dyskinesia (TD). The goals of the presentation were to describe the effect of TD on patient outcomes, barriers to care, and note the prevalence of TD in those who are taking antipsychotic medication. In addition to this, faculty reviewed updated recommendations and screening strategies for better recognition of TD as well as guideline recommendations outlining treatment and best practices.

Reference: Psych Regionals: Tardive Dyskinesia Across the Complexity Spectrum – From Quality of Life Improvement to Novel Treatments. HMP Global Learning Network. Published December 1, 2021. Accessed May 17, 2022. https://hmpeducation.com/program/pcr21-td360